Controlled trial of antithrombin III supplementation in fulminant hepatic failure

Langley, Peter G., Hughes, Robin D., Forbes, Alastair ORCID: https://orcid.org/0000-0001-7416-9843, Keays, Rick and Williams, Roger (1993) Controlled trial of antithrombin III supplementation in fulminant hepatic failure. Journal of Hepatology, 17 (3). pp. 326-331. ISSN 0168-8278

Full text not available from this repository. (Request a copy)

Abstract

Patients with fulminant hepatic failure have severe circulatory disturbances which may be due to fibrin and cellular plugs in micro-vessels which are a consequence of intravascular coagulation and which can lead to multiorgan failure. Since antithrombin III supplementation has been shown to be beneficial in animal models of septic shock with disseminated intravascular coagulation, a controlled study was performed to investigate the effect of antithrombin III supplementation in fulminant hepatic failure. Twenty-five patients in grade III or IV coma were selected on the basis of evidence of sepsis, intravascular coagulation and a high risk of developing multiorgan failure. Thirteen patients received 3000 units of antithrombin III (Kybernin P; Behringwerke), followed by a further 1000 units every 6 h. Antithrombin III activity increased from 0.26 +/- 0.04 SE U/ml to 0.82 +/- 0.07 U/ml at 3 h post infusion (normal range 0.80-1.20 U/ml) and remained greater than 0.80 U/ml throughout the study without any apparent increase in the frequency of bleeding. However, survival was not improved and markers of intravascular coagulation remained similar between the two groups. Thus, although the antithrombin III deficiency in fulminant hepatic failure can be corrected by supplementation with antithrombin III concentrate, its use in the prevention of intravascular coagulation and to avoid microvessel plugging needs to be studied at an earlier stage in the disease.

Item Type:	Article
Uncontrolled Keywords:	adolescent,adult,aged,antithrombin iii,blood coagulation disorders,female,hemorrhage,hepatic encephalopathy,humans,male,middle aged,multiple organ failure,prognosis,retrospective studies,risk factors,survival rate
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Nutrition and Preventive Medicine Faculty of Medicine and Health Sciences > Research Groups > Gastroenterology and Gut Biology
Depositing User:	Pure Connector
Date Deposited:	06 Aug 2014 10:50
Last Modified:	20 Oct 2022 23:57
URI:	https://ueaeprints.uea.ac.uk/id/eprint/49535
DOI:	10.1016/S0168-8278(05)80213-2

Actions (login required)

View Item